Concepedia

LP37 : A placebo-controlled, multicenter, double-blind, randomised trial of emricasan in subjects with non-alcoholic fatty liver disease (NAFLD) and raised transaminases

Mitchell L. Shiffman, B. Freilich, Raj Vuppalanchi, Kymberly D. Watt, Gary Burgess, M. Morris, Beth Sheedy, Eugene R. Schiff

Journal of Hepatology · 2015 · 30 citations · 0 references

DOI

Concepts